targeted alpha therapy tat inhibit growth micrometastases selectively killing isolated preangiogenic clusters cancer cells alpha emitting radioisotopes chelated cancer specific monoclonal antibodies form aic melanoma leukaemia prostate colorectal cancer plasminogen activator inhibitor pai2 form api breast prostate cancer conjugates highly stable specific cytotoxic vitro melanoma breast cancer tumour growth observed nude mouse models untreated controls NUMBER days inoculation cancer cells complete inhibition melanoma breast cancer growth local injections aic api respectively tat established melanoma showed melanomas regressed NUMBER microci injections aic results point potential application local systemic tat management metastatic cancer tb NUMBER bi NUMBER alpha immunoconjugates type NUMBER alpha pai2 non specific post subcutaneous intra lesional aic api